Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: included female adults diagnosed with non-metastatic invasive breast cancer and had received their standard treatment and were: 1) Triple-negative breast cancer (TNBC) or , 2) Hormonal receptor positive /HER2neu negative if locally advanced &/or had high-risk pathological features. ?whose age range from (18 -80)
Exclusion criteria
Exclusion criteria: 1) Patients positive for Human Epidermal Growth Factor-2 (HER-2) subtype of breast cancer, 2) Patients scored > 2 on the Eastern Cooperative Oncology Group (ECOG) performance status scale . 3) Patients with any medical condition that could interfere with chemotherapy administration .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2 year disease free survival calculated fromthedateofstudyentry until time of development of local or/& distant metastasis. | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival measured from the time of participation in the study until the last follow up visit or death. | — |
Countries
Egypt
Contacts
assistant professor of clinical oncology at suez canal university